Drug intelligence / Profile preview

crocin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Crocin is a natural carotenoid chemical compound primarily found in the flowers of *Crocus sativus* (saffron) and gardenia. It is responsible for saffron’s distinctive red color and is chemically a diester formed from the disaccharide gentiobiose and the dicarboxylic acid crocetin[4][5]. The term "crocin" can refer to several closely related hydrophilic carotenoids that are mono- or diglycosyl polyene esters of crocetin[2][4]. Crocin exhibits multiple pharmacological activities including antioxidant, anti-inflammatory, anticancer, neuroprotective (notably in models of neurodegenerative diseases such as Parkinson's and Alzheimer's), antidepressant effects, memory improvement properties as well as potential benefits in cardiovascular health by acting as an anti-hypertensive and anti-atherosclerotic agent[2][5]. Mechanistically it acts mainly through radical scavenging activity against superoxide anions and by modulating oxidative stress pathways. In experimental settings it has shown protective effects on brain vasculature, renal tissues, heart tissue and retina[2][5]. Crocin also finds use as a natural food coloring due to its water solubility. Its bioavailability when taken orally is limited until hydrolyzed to trans-crocetin in the intestine[2].

Other names
crocins (for the class of related compounds)trans-crocetin di-(β-D-gentiobiosyl) ester
02

Targets

ATP5B (Mitochondrial F1-ATPase)UQCRC1 (Ubiquinol-cytochrome c reductase complex core protein 1)DNAPRDX2 (Peroxiredoxin-2)TUBB (Tubulin (alpha and beta subunits))ACT (Actin beta-like protein 2)

Beyond the preview

Go deeper on crocin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on crocin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call